Labcorp Holdings Inc.
LH- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0000920148
In the last 90 days, Labcorp Holdings Inc. insiders filed 0 open-market purchases and 3 sales; 1,064 institutions reported holding it in 13F filings for Q2 2026, worth $22.2B in total; Weitz Investment Management is the only superinvestor holding it.
Key figures
- Market capClose on Nov 10, 2026
- $30.1B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $1.45M in total
- 3
- 13F holdersQ2 2026, +31 vs. previous quarter
- 1,064
- 13F valueReported value at the end of Q2 2026
- $22.2B
- Superinvestors holdingAt the end of Q2 2026
- 1
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $14.0B
- +7.2% year over year
- Net income, FY2025
- $876.5M
- +17.5% year over year
- Free cash flow, FY2025
- $1.21B
- +10.0% year over year
- Revenue, Q3 FY2026
- $3.81B
- +6.9% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 2.54M
- Shares sold short
- Change
- −13.2K
- −0.5% vs. previous
- Days to cover
- 3.01
- At average daily volume
Superinvestors holding LH, Q2 2026
Go to the superinvestors tab1 superinvestor reports holding Labcorp Holdings Inc. on Form 13F. Percentages are the stock's share of each portfolio.
Weitz Investment Management
Wally Weitz
1.9%
Labcorp Holdings Inc.'s share of the portfolio
- Shares
- 99,050
- Value
- $27.7M
Latest insider trades
See all insider tradesOpen-market purchases and sales by Labcorp Holdings Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 5, 2026 (view filing)8:00 AM ET | Nov 3 | 2 days | Vaughn Bryan TEVP and President, Diagnostics | SSale | −306 | $353.70 | −$108.2K | −4.3%6.84K after | 10b5-1 |
| Nov 3, 2026 (view filing)10:17 AM ET | Oct 30 | 4 days | Parham Richelle PDirector | SSale | −1.08K | $361.22 | −$389.4K | −32.0%2.29K after | |
| Aug 18, 2026 (view filing)8:10 AM ET | Aug 17 | 1 day | Anderson Kerrii BDirector | SSale | −3.00K | $318.02 | −$954.1K | −31.4%6.56K after | 10b5-1 |
| Aug 12, 2026 (view filing)2:31 PM ET | Aug 11 | 1 day | Schechter Adam HPresident & CEO | SSale | −4.67K | $320.37 | −$1.50M | −4.4%102.6K after | 10b5-1 |
| Aug 6, 2026 (view filing)8:26 AM ET | Aug 4 | 2 days | Summy Amy B.EVP, Chief Marketing Officer | SSale | −924 | $306.74 | −$283.4K | −11.7%6.96K after | |
| Aug 5, 2026 (view filing)11:17 AM ET | Aug 3 | 2 days | Wilkinson Peter JSVP, Chief Accounting Officer | SSale | −1.42K | $309.23 | −$439.1K | −44.5%1.77K after | 2 lots |
| Jul 6, 2026 (view filing)9:37 AM ET | Jul 2 | 4 days | Kyle Kathryn WEVP, Chief Legal Officer | SSale | −92 | $286.19 | −$26.3K | −2.3%3.90K after | 10b5-1 |
| Jul 6, 2026 (view filing)9:36 AM ET | Jul 2 | 4 days | Vaughn Bryan TEVP and President, Diagnostics | SSale | −234 | $286.19 | −$67.0K | −3.4%6.75K after | 10b5-1 |
| Jun 10, 2026 (view filing) | Jun 8 | 2 days | Kyle Kathryn WEVP, Chief Legal Officer | SSale | −762 | $263.89 | −$201.1K | −16.7%3.81K after | 10b5-1 |
| May 13, 2026 (view filing) | May 11 | 2 days | Schechter Adam HPresident & CEO | SSale | −5.90K | $254.50 | −$1.50M | −5.2%107.2K after | 10b5-1 |
Top 10 13F holders, Q2 2026
See all 1,064 holdersThe largest institutional positions in Labcorp Holdings Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 6,574,261 | $1.84B | 0.03% | +129,405+2.0% | Added |
| Vanguard Capital Management LLC | 5,362,254 | $1.50B | 0.03% | −13,866−0.3% | Reduced |
| Victory Capital Management Inc | 4,837,573 | $1.35B | 0.76% | +210,447+4.5% | Added |
| State Street Corp | 3,907,656 | $1.09B | 0.03% | +44,485+1.2% | Added |
| Vanguard Portfolio Management LLC | 3,678,798 | $1.03B | 0.05% | −1,863−0.1% | Reduced |
| Boston Partners | 3,051,690 | $854.2M | 0.76% | +682,894+28.8% | Added |
| Allspring Global Investments Holdings, LLC | 2,236,957 | $635.0M | 0.97% | +10,511+0.5% | Added |
| Geode Capital Management, LLC | 2,188,890 | $610.4M | 0.03% | +2,948+0.1% | Added |
| Select Equity Group, L.P. | 1,981,948 | $554.9M | 2.94% | −192,837−8.9% | Reduced |
| FMR LLC | 1,904,870 | $533.4M | 0.02% | +616,459+47.8% | Added |
Holders of 5% or more of LH
See all 2 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Labcorp Holdings Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 7.60%6.33M shares | – | Oct 18, 20242 filings | Apr 24, 2025 | SEC |
| Vanguard Capital Management LLC | 13G | 7.52%6.20M shares | New | Apr 28, 20261 filing | Apr 28, 2026 | SEC |
Politician trades
All politician trades in LH9 members of Congress reported 28 trades in Labcorp Holdings Inc. since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Sep 9, 2026 |  April McClain Delaney House · MD | Sell | $100K-$250K |
| Sep 9, 2026 | April McClain Delaney House · MD | Sell (partial) | $1K-$15K |
| Sep 9, 2026 | April McClain Delaney House · MD | Sell (partial) | $1K-$15K |
| Sep 9, 2026 | April McClain Delaney House · MD | Sell (partial) | $1K-$15K |
| Jul 21, 2026 |  Alan Armstrong Senate · OK | Buy | $1K-$15K |
House · MD · Sep 9, 2026
Sell$100K-$250K
House · MD · Sep 9, 2026
Sell (partial)$1K-$15K
House · MD · Sep 9, 2026
Sell (partial)$1K-$15K
House · MD · Sep 9, 2026
Sell (partial)$1K-$15K
Senate · OK · Jul 21, 2026
Buy$1K-$15K